# OnCo record ak146d1 (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/ak146d1/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "ak146d1" ;
  schema:name "AK146D1"@en ;
  schema:description "AK146D1 is Akeso's Nectin-4 × TROP2 bispecific ADC, combining the two most validated ADC addresses in one molecule."@en ;
  schema:url <https://onco.cc/drugs/ak146d1/> ;
  schema:dateModified "2026-09-04"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT06929663>, <https://www.akesobio.com/en/> ;
  onco:status "phase-1" ;
  onco:modality "Bispecific ADC" ;
  onco:cancers <https://onco.cc/cancers/urothelial/>, <https://onco.cc/cancers/tnbc/>, <https://onco.cc/cancers/nsclc/> ;
  onco:technologies <https://onco.cc/technologies/bispecific-adc/> ;
  onco:targets <https://onco.cc/targets/nectin4/>, <https://onco.cc/targets/trop2/> ;
  onco:companies <https://onco.cc/companies/akeso/> ;
  onco:trials <https://onco.cc/trials/nct07669779/>, <https://onco.cc/trials/nct07591090/> .